Clik here to view.
Loncar China BioPharma ETF (CHNA) Celebrates One-Year Anniversary
LENEXA, Kan. The Loncar China BioPharma ETF (Nasdaq: CHNA) today celebrates one year of trading on the Nasdaq in the United States. The fund gives investors exposure to 29 companies at the heart of...
View ArticleSinovac Reports Unaudited Second Quarter 2019 Financial Results
BEIJING Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the second...
View ArticleClik here to view.
Steven Rosenberg博士因其癌症免疫治疗的先驱性工作而荣获2019年江户川NICHE奖
东京 (美国商业资讯)–江户川NICHE委员会(The Edogawa NICHE Committee)今天宣布，2019年江户川NICHE奖(Edogawa NICHE Prize, www.edogawanicheprize.org)授予Steven A....
View ArticleClik here to view.
Clik here to view.
Dr. Reddy’s Laboratories announces the launch of Versavo® (bevacizumab...
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Versavo® (bevacizumab), a biosimilar of Roche’s Avastin® in India,...
View ArticleClik here to view.
NUS, Agilent, and NUH Launch New Translational R&D Hub to Boost Clinical...
SINGAPORE The National University of Singapore (NUS), Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, and National University Hospital (NUH), have...
View ArticleClik here to view.
Q-Sera’s Innovative Blood Clotting Technology Granted Patent in US
MELBOURNE, Australia Medical device company Q-Sera Pty Ltd today announces that it has received a Notice of Allowance from the United States Patent & Trademark Office for the foundation patent...
View ArticleClik here to view.
Cidara Therapeutics to Present Data from its Cloudbreak Antiviral Program at...
SAN DIEGO Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that five abstracts, including one...
View ArticleClik here to view.
Propanc Biopharma Receives Granted US Patent Covering Additional Composition...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer,...
View ArticleClik here to view.
Bioasis Announces Registration and Grant Notice of Patent Application in...
GUILFORD, Conn. BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform...
View ArticleClik here to view.
Cantargia and BioWa Extend Ongoing Collaboration around the POTELLIGENT®...
LUND, Sweden & PRINCETON, N.J. Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENT® Technology for production of Cantargia’s...
View ArticleClik here to view.
Clik here to view.
Study Investigates the Utility of Masimo ORi™, Oxygen Reserve Index, to...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today that in a randomized controlled study involving 150 ICU patients recently published as a letter in Intensive Care Medicine, researchers...
View ArticleClik here to view.
Myomoが国際市場向けの技術ライセンス計画を発表
米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — 神経疾患と上肢まひを患う方々のための機能向上を実現するウエアラブルメディカルロボット企業のMyomo, Inc.（NYSE American:...
View ArticleClik here to view.
Poxel Reports Financial Results for First Half 2019 and Provides Corporate...
LYON, France POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and...
View ArticleClik here to view.
Great Bay Bio’s 3D Advisory Board Science Committee Welcomes Another New Arrival
HONG KONG Great Bay Bio, a leading AI biotechnology company dedicated to big data-driven CMC (Chemistry Manufacturing and Controls) development of innovative biologics, is pleased to announce that...
View ArticleClik here to view.
研究显示，危重病患者使用Masimo ORi™（氧储备指数）可减少高氧
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，《重症监护医学》最新发表的一篇有关150例ICU患者随机对照研究的通讯中，研究人员评估，与单纯氧饱和度(SpO2)监测相比，Masimo...
View ArticleClik here to view.
HemaCare and Charles River Laboratories Partner to Provide Human-Derived...
LOS ANGELES HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery,...
View ArticleClik here to view.
Pancreatic Cancer Action Network and CDISC Partner to Develop First...
MANHATTAN BEACH, Calif & AUSTIN, Texas The Pancreatic Cancer Action Network (PanCAN), the leading pancreatic cancer patient advocacy organization, and CDISC, the global nonprofit dedicated to...
View ArticleClik here to view.
危篤患者における酸素過剰を低減するMasimo ORi™（予備酸素摂量指数）の有用性を検討する研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、インテンシブ・ケア・メディシン誌にレター論文として掲載され、ICU患者150人が参加したランダム化対照研究において、研究者らがMasimo...
View Article